๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

U.S. drug and biologic approvals in 1996

โœ Scribed by John F. Beary III; Lara E. Robillard; Gillian R. Woollett; John D. Siegfried; Thomas X. White; David A. Shriver

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
176 KB
Volume
40
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

โœฆ Synopsis

Since the introduction of the Prescription Drug User Fee Act of 1992, the mean approval time for new drugs has decreased from 29.9 months (1992) to 17.8 months (1996).

๐Ÿ“œ SIMILAR VOLUMES

U.S. drug and biologic approvals in 1994
U.S. drug and biologic approvals in 1994โ€“1995
โœ John F. Beary III; Christina M. Duchaine; Reginald W. Rhein Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 784 KB

Since the introduction of the Prescription D r u g User Fee in 1992, the mean approval time for new drugs has decreased from 29.9 months (1992) t o 19.2 months (1995). In 1994, 22 new drugs and 1 biological were approved. In 1995, 28 drugs and 2 biologicals were approved.

U.S. drug and biologic product approvals
U.S. drug and biologic product approvals during 1993
โœ John F. Beary III; C. Robert Eaton; Thomas L. Copmann; Dale E. Wierenga ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 485 KB ๐Ÿ‘ 1 views
US drug and biologic approvals in 1998
US drug and biologic approvals in 1998
โœ Bert Spilker; Stacey FitzSimmons; Michael Horan ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 137 KB ๐Ÿ‘ 1 views

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past 3 years have seen an unprecedented approval of 122 new drugs and 28 new biologics. Information is provided on the 39 new products approved by the

US drug and biologic approvals in 1997
US drug and biologic approvals in 1997
โœ John F. Beary III; John D. Siegfried; Renee Tavares ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 837 KB

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past two years have seen an unprecedented approval of 92 new drugs and 19 new biologics. Information is provided on the 49 new products approved by the FDA in 1997.